Colony Financial, Inc. (the "Company") (NYSE: CLNY) today announced it has commenced an underwritten public offering of additional shares of its
shares of Series A Cumulative Redeemable Perpetual Preferred Stock with liquidation preference of $25 per share.
Barclays Capital Inc, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley & Co. LLC and UBS Securities LLC are acting as joint book-running managers for the offering. RBC Capital Markets, LLC and Stifel, Nicolaus & Company, Incorporated are acting as co-managers. The Company expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of Series A Cumulative Redeemable Perpetual Preferred Stock initially sold to the public to cover overallotments, if any. The outstanding shares of Series A Cumulative Redeemable Perpetual Preferred Stock currently trade on the New York Stock Exchange under the symbol "CLNYPrA". The Company will apply to list the additional shares on the New York Stock Exchange under the same symbol.
The Company intends to use the proceeds from the offering to repay amounts outstanding under the Company’s revolving credit facility and the balance for working capital and general corporate purposes.
A registration statement relating to these securities has been declared effective by the Securities and Exchange Commission. The offering will be made only by means of a prospectus supplement and prospectus, which have been filed with the Securities and Exchange Commission. A copy of the prospectus supplement and prospectus related to the offering can be obtained, when available, by contacting Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, telephone: (888) 603-5847 or by email at
; Merrill Lynch, Pierce, Fenner & Smith Incorporated, 4 World Financial Center, New York, NY 10080, Attention: Prospectus Department, telephone: (800) 294-1322 or by e-mail at
; Morgan Stanley & Co. LLC, 180 Varick Street, 2nd Floor, New York, NY 10014, Attention: Prospectus Department, telephone: (866) 718-1649 or by e-mail at
; or UBS Securities LLC, 299 Park Avenue, New York, NY 10171, Attention: Prospectus Specialist, telephone: (877) 827-6444, ext. 561 3884.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of any securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.